1 The present study was designed to examine the effects of a centrally acting 5-HTIA receptor agonist, flesinoxan, on the cardiovascular system and renal haemodynamics and excretory function. 2 In chloralose-urethane anaesthetized Wistar rats, i.v. administration of bolus doses of flesinoxan, at 30, 100, 300 and 1000 jig kg-', caused significant, dose-dependent decreases in mean arterial pressure, of 33 ± 2 mmHg (P<0.001) and heart rate of 57 ± 9 beats min-' (P<0.001) at the highest dose used. Despite this substantial fall in perfusion pressure there were no meaningful changes in the renal excretion of water and sodium. In a second group of rats, reduction of renal perfusion pressure mechanically to the same values as observed in rats given flesinoxan (i.e. 100, 92, 84 and 76 mmHg) produced reductions in urine flow, absolute and fractional sodium excretions reaching a maximum of 74, 86 and 84% respectively (all P <0.001) at the lowest pressure. These reductions were significantly larger than those seen in the previous group of animals. 3 In the group of rats subjected to renal denervation, flesinoxan produced changes in blood pressure and heart rate which were not different from those observed in intact animals. However, the reduction in pressure was accompanied by significant decreases in urine flow of 71 %, absolute sodium excretion of 68% and fractional sodium excretion of 67% (all P<0.001) at the highest dose, which were all significantly greater than the changes seen in the innervated animals but were not different from those observed when renal perfusion pressure was reduced mechanically. 4 The findings of this investigation showed that flesinoxan was effective in lowering blood pressure and heart rate in the anaesthetized rat, which was probably due to decreased sympathetic nerve activity. Renal excretion of water and sodium was well preserved in the face of the flesinoxan-induced hypotension. The maintenance of fluid excretion with flesinoxan appeared to be mediated via changes in renal nerve activity, since it did not occur when the kidney was denervated.
Introduction
In recent years evidence has accumulated to show that central neural pathways utilising 5-hydroxytryptamine (5-HT) contribute towards the control of the sympathetic nervous system. Application of 5-HT to lateral ventricles of the cat brain was found to cause a fall in blood pressure, to reduce heart rate and inhibit efferent sympathetic nerve activity (Baum & Shropshire, 1975) . In later studies several subtypes of receptors for 5-HT were identified in the brain (Peroutka, 1988) of which the 5-HTA subtype appeared to mediate the reduction in sympathetic outflow as a result of centrally applied (Gdthert & Schlicker, 1990) . Subsequently specific agonists of this receptor site were developed, such as 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) (Peroutka et al., 1990) , and used to determine the effects of 5-HTIA receptor stimulation on the degree of activation of the sympathetic nervous system and thereby the status of the cardiovascular system. There have been a number of reports in which agonists of this receptor site have been shown to reduce blood pressure and heart rate after intravenous (Gradin et al., 1985; Dreteler et al., 1990) , intra-arterial (Dreteler et al., 1991) and intracisternal administration . These responses appeared to be mediated by receptors located in dorsal raphe nucleus of the brain (Laubie et al., 1989; Connor & Higgins, 1990) . More recently Ramage and co-workers have provided evidence in the cat that centrally acting 5-HTA receptor agonists produce peripheral sympatho-inhibition, with efferent renal nerve activity being most sensitive (Ramage et al., 1988 ; Ramage & Wilkinson, 1989 ).
The kidney is very richly innervated with the renal sympathetic nerves supplying the renal vasculature, tubules and juxtaglomerular apparatus (Barajas et al., 1992) . It has been shown, both in studies utilising direct renal nerve stimulation as well as in denervation experiments, that the renal nerves can influence renal haemodynamics, tubular sodium reabsorption and renin release from juxtaglomerular cells (DiBona et al., 1988; Johns, 1991) . In terms of function, the electrical activity in the renal sympathetic nerves has been shown to change in response to such physiological stimuli as variations in arterial blood pressure (Deka-Starosta et al., 1989) and intravascular volume (DiBona et al., 1988) which consequently determines the level of renal haemodynamics and fluid excretion.
Given the important influence of the renal nerves upon sodium and water excretion and existing evidence that stimulation of central 5-HTIA receptors can decrease efferent renal sympathetic nerve activity, the aim of the present investigation was to examine the effects of the specific 5-HTlA agonist, flesinoxan, on the cardiovascular system and renal nervedependent change in renal haemodynamics and water and sodium excretion in anaesthetized, normotensive rats. A preliminary account of this work was presented to the Pharmacological Society meeting at Bradford in September 1993 (Chamienia & Johns, 1993) .
Methods
The experiments were performed on male Wistar rats (mean body weight 300 g) which had been fasted overnight. the hard disk for later off-line analysis. On completion of the surgery, a priming dose of 2 ml inulin in saline (1.5 g 100 ml-') was given i.v. and isotonic saline infusion replaced by one containing inulin (L.5 g 100 ml'). Animals were then allowed 2 h to stabilize and reach equilibrium before starting the experiment.
Experimental protocols
In this study, urine was collected from the ureters over 15 min and this was termed a clearance period. Five Group 3 (n = 6). In this group of animals, in addition to the surgery described above, the left renal sympathetic nerves were identified, carefully dissected and cut. Only left kidney function was studied in this group. Rats received flesinoxan at the same doses as in group 1.
Chemical assays
Urinary and plasma electrolyte concentrations were measured by flame photometry (Ciba Corning 410C). Plasma and urine samples inulin was measured as described previously (Chamienia & Johns, 1991 
Results
Figure 1 presents the mean arterial pressure, renal perfusion pressure and heart rate in the three groups of experiments. In the first group, flesinoxan caused dose-dependent falls in both mean arterial pressure and renal perfusion pressure, of 33 ± 2 and 34 ± 2 mmHg respectively at the highest dose (both P<0.001). This was accompanied by a progressive decrease in heart rate reaching some 57 ± 9 beats min' (P <0.001) at the highest dose of the drug. Renal blood flow (RBF) and glomerular filtration rate (GFR) did not change significantly throughout the experiment. Despite the profound fall in perfusion pressure, the left kidney urine flow (UV), urinary sodium excretion (UNaV) and fractional sodium excretion (FENa) fell only slightly but not significantly by 28, 29 and 16% respectively, at the highest dose of drug. At the same time, right kidney UV, UNaV and FENa were slightly, but not significantly, raised by 13, 14 and 11% respectively (Figure 2 ).
In the second group of animals, mean arterial pressure increased slightly by 8 ± 6 mmHg during stepwise reduction in left renal perfusion pressure. Levels of perfusion pressure obtained by applying aortic constriction were very similar to those observed in the animals in group 1 (Figure 1 ). Heart rate did not change at any time throughout the experiment in this group of rats, which was significantly different from the dose-related decreases in heart rate observed in the group 1 rats given flesinoxan (P <0.001). RBF Figure 3 .
Discussion
The purpose of the present study was to investigate the renal functional responses to 5-HTlA receptor stimulation by a specific agonist and to determine the role, if any, of the renal sympathetic nerves. The results from the normotensive Wistar rats showed that intravenous administration of flesinoxan caused dose-dependent decreases in blood pressure which were accompanied by falls in heart rate. This was in agreement with previously published results of studies in cats (Dreteler et al., 1989) and rats (Dreteler et al., 1990) . It The P values are generated in the comparison between the group 1 data and that of group 2 or 3 using repeated measures ANOVA.
resistance. Dreteler et al. observed a reduction in vascular resistance in renal and cerebral circulations, but no change in cardiac output after flesinoxan administration in cats (Dreteler et al., 1989) and spontaneously hypertensive rats (Dreteler et al., 1991 ). An increase in vagal tone appears to contribute to the bradycardia since this effect was reported to be abolished by atropine and vagotomy in the cat (Ramage et al., 1988) . In our experiments flesinoxan had little effect on glomerular filtration rate (GFR) or renal blood flow (RBF). This demonstrates that over this range of perfusion pressure both RBF and GFR were effectively autoregulated. However, despite the profound fall in blood pressure, renal excretion of urine and sodium was well preserved. This response was intriguing as it has been shown previously, that urine and sodium excretions depend critically on the level of renal perfusion pressure (pressure-natriuresis) (Roman & Cowley, 1985; Roman et al., 1988) and therefore it might have been anticipated that urinary volume and sodium excretion would decrease in parallel with the hypotension. Indeed, in the study in which renal perfusion pressure was lowered by the means of aortic constriction to levels similar to those observed with flesinoxan, urine flow, absolute and fractional sodium excretions all fell significantly along with perfusion pressure. The mechanism by which renal excretory function was preserved in the presence of flesinoxan is not clear. Baum & Shropshire (1975) in early experiments were able to show an inhibition of efferent renal sympathetic nerve activity (ERSNA) due to a central action of 5-HT. More recently, Stein et al. (1987) and Montes & Johnson (1990) (DiBona, 1989) . This view has been supported by experiments which showed that renal denervation could enhance excretion of water and sodium without changes in renal haemodynamics (Pelayo et al., 1983; Bencsath et al., 1985) . Furthermore, such physiological stimuli as variations in arterial blood pressure (Deka-Starosta et al., 1989) and intravascular volume (DiBona et al., 1988) Although the effects of flesinoxan in our study appear to be mediated via a central mechanism it is of interest that 5-HTIA receptors have recently been found in rat and human kidneys. Those receptors appear to be present on the basolateral membranes of the cells in medullary and cortical thick ascending limbs, distal convoluted tubules and initial portion of collecting tubules (Raymond et al., 1993 
